Top Clinical Trials companies in Australia by Total Non-Current Liabilities
Australia
# |
Name |
Total Non-Current Liabilities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 13.67 B
|
June 30, 2024 | USD 169.95 | -0.56% |
|
Australia |
|
| 2 |
USD 138.41 M
|
June 30, 2024 | USD 2.33 | 0.08% |
|
Australia |
|
| 3 |
USD 115.56 M
|
June 30, 2024 | USD 1.90 | -4.74% |
|
Australia |
|
| 4 |
USD 95.34 M
|
June 30, 2024 | USD 0.74 | 0.62% |
|
Australia |
|
| 5 |
USD 62.64 M
|
Dec. 31, 2023 | USD 18.33 | -0.84% |
|
Australia |
|
| 6 |
USD 8.90 M
|
June 30, 2024 | USD 1.23 | -0.40% |
|
Australia |
|
| 7 |
USD 4.33 M
|
June 30, 2024 | USD 0.74 | 1.48% |
|
Australia |
|
| 8 |
USD 2.19 M
|
Dec. 31, 2023 | USD 6.16 | 2.82% |
|
Australia |
|
| 9 |
USD 1.93 M
|
June 30, 2024 | USD 7.27 | 0.71% |
|
Australia |
|
| 10 |
USD 1.05 M
|
June 30, 2024 | USD 2.09 | 0.97% |
|
Australia |
Frequently Asked Questions
-
Which Clinical Trials company in Australia has the highest Total Non-Current Liabilities ?
The Clinical Trials company in Australia with the highest Total Non-Current Liabilities is CSL Limited (ASX: CSL.AX) at USD 13.67 B.
-
Which Clinical Trials company in Australia has the lowest Total Non-Current Liabilities ?
The Clinical Trials company in Australia with the lowest Total Non-Current Liabilities is Immutep Limited (NasdaqGM: IMMP) at USD 1.05 M.
-
What are the top 10 Clinical Trials companies in Australia by Total Non-Current Liabilities ?
The top 10 Clinical Trials companies in Australia by Total Non-Current Liabilities are CSL Limited, Australian Clinical Labs Limited, Mesoblast Limited, Monash IVF Group Limited, Telix Pharmaceuticals Limited, PolyNovo Limited, Cogstate Limited, Anteris Technologies Ltd, Clinuvel Pharmaceuticals Limited and Immutep Limited.
-
What are the bottom 10 Clinical Trials companies in Australia by Total Non-Current Liabilities ?
The bottom 10 Clinical Trials companies in Australia by Total Non-Current Liabilities are Immutep Limited, Clinuvel Pharmaceuticals Limited, Anteris Technologies Ltd, Cogstate Limited, PolyNovo Limited, Telix Pharmaceuticals Limited, Monash IVF Group Limited, Mesoblast Limited, Australian Clinical Labs Limited and CSL Limited.
